Blood
Publisher: Elsevier · ISSN 0006-4971 · 65 articles
- Negrin RS, Meyer EH. CD4+CD25+FOXP3+ regulatory T cells to protect against graft-versus-host disease. Blood. 2026;148(11):1381-1387.
- How I Treat Hypereosinophilic Syndrome with Eosinophil-Targeting Biologics
- Multimodal omics identifies a lymphoid-biased multipotent progenitor population with limited age-associated remodeling
- CD20-directed Autologous CAR T-cell Therapy for Waldenström Macroglobulinemia
- Mechanistically distinct classes of BCR::ABL1 mutations confer resistance to asciminib
- Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm
- Upfront whole genome and transcriptome sequencing to improve diagnosis in inherited bone marrow failure syndromes
- Detection, monitoring, and discrimination of amyloidogenic vs innocent light chains in systemic amyloidoses
- International Cross-Age Consensus Guideline on Measurable Residual Disease Assessment in Acute Lymphoblastic Leukemia
- Terminal differentiation program of CD8 T cells guides immunotherapeutic options for CLL patients
- Nuclear Receptor Nur77 Orchestrates Hematopoietic Lineage Commitment to Avert Anemia in Diabetes
- Pivekimab sunirine and the evolving treatment of blastic plasmacytoid dendritic cell neoplasm
- Is Circulating Tumor DNA Ready for Clinical Use in Large B-cell Lymphoma?
- The Pathogen Recognition Receptor RIG-I is Functional in Platelets and Limits Thrombotic Responses
- Table of Contents
- Editorial Board
- Fit for the fight: BTK inhibitors prime CAR T cells in CLL
- The new Iron Age in polycythemia vera
- Beyond provoked and unprovoked: guiding clinical decisions
- Correcting a genetic overSTATement
- Et tu, CD70? When friend turns foe for follicular lymphoma
- A clone by any other name: convergence of CCUS and LR-MDS
- Targeting TMPRSS6 in β-thalassemia: of mice and men
- Pathological effects of NETs: seed and soil hypothesis for inflammation spread by primed neutrophils
- Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004
- Sapablursen for erythrocytosis control in patients with polycythemia vera
- Risk of recurrence in patients with provoked venous thromboembolism: a prospective cohort study
- Functional restoration of immune defects in STAT1 gain-of-function disease after stem cell gene editing
- CD70 overexpression at diagnosis predicts relapse and supports dual CD19-CD70 CAR T-cell therapy in follicular lymphoma
- Clinical and genomic convergence of high-risk CCUS and lower-risk myelodysplastic syndromes/neoplasms